David K. Gieser

Large Diurnal Fluctuations in Intraocular Pressure Are an Independent Risk Factor in Patients With Glaucoma

Sanjay Asrani, R. Zeimer, Jacob T. Wilensky et al. · Journal of Glaucoma · 2000 · 891 citations

Health Professions, Ophthalmology, Optometry +16

Follow-up of Angle-closure Glaucoma Suspects

Jacob T. Wilensky, Paul L. Kaufman, Diane Frohlichstein et al. · American Journal of Ophthalmology · 1993 · 162 citations

Medicine, Ophthalmology, Surgery +12

Association between Intraocular Pressure Peaks and Progression of Visual Field Loss

R. Zeimer, Jacob T. Wilensky, David K. Gieser et al. · Ophthalmology · 1991 · 156 citations

Medicine, Ophthalmology, Optometry +14

Individual Variability in the Diurnal Intraocular Pressure Curve

Jacob T. Wilensky, David K. Gieser, Mary Lynn Dietsche et al. · Ophthalmology · 1993 · 152 citations

Medicine, Ophthalmology, Physiology +12

A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide11Ms. Boyle, Dr. Ghosh, and Dr. Adamsons were employees of Merck & Co., Inc, the manufacturer of timolol and dorzolamide, at the time this study was conducted. COSOPT and TRUSOPT are trademark products of Merck & Co., Inc, Whitehouse Station, New Jersey. The other authors have no proprietary interest in timolol, dorzolamide, or Merck.

Janet E Boyle, Kalyan Ghosh, David K. Gieser et al. · Ophthalmology · 1998 · 150 citations

Medicine, Pharmacology, Pharmacotherapy +8